Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
Condition: Relapsing Remitting Multiple SclerosisInterventions: Drug: BG00002 (natalizumab); Drug: interferon beta-1a; Drug: glatiramer acetateSponsors: Biogen Idec; Elan PharmaceuticalsTerminated - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2010 Category: Research Source Type: clinical trials
Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
Condition: Relapsing Remitting Multiple SclerosisInterventions: Drug: BG00002 (natalizumab); Drug: interferon beta-1a; Drug: glatiramer acetateSponsors: Biogen Idec; Elan PharmaceuticalsTerminated - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2010 Category: Research Source Type: clinical trials
Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
Condition: Relapsing Remitting Multiple SclerosisInterventions: Drug: BG00002 (natalizumab); Drug: interferon beta-1a; Drug: glatiramer acetateSponsors: Biogen Idec; Elan PharmaceuticalsTerminated - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2010 Category: Research Source Type: clinical trials
Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA)
Condition: Multiple SclerosisIntervention: Drug: CopaxoneSponsors: University at Buffalo; Teva Neuroscience, Inc.Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 9, 2009 Category: Research Source Type: clinical trials
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Relapsing Remitting Multiple SclerosisInterventions: Drug: Estriol; Drug: PlaceboSponsors: University of California, Los Angeles; Washington University School of Medicine; University of Texas Southwestern Medical Center; Ohio State University; University of Medicine and Dentistry of New Jersey; University of Chicago; Western Institute for Biomedical Research, Salt Lake City, UT; Johns Hopkins University; University of Kansas; University of Minnesota - Clinical and Translational Science Institute; Mayo Clinic; University of Colorado, Au...
Source: ClinicalTrials.gov - March 22, 2007 Category: Research Source Type: clinical trials
